Apoptosis: Its role in the development of malignancies and its potential as a novel therapeutic target

被引:74
作者
Dixon, SC
Soriano, BJ
Lush, RM
Borner, MM
Figg, WD
机构
[1] NCI, DIV CLIN RES,CLIN PHARMACOL BRANCH, CLIN PHARMACOKINET SECT,NIH, BETHESDA, MD 20892 USA
[2] UNIV BERN, INST MED ONCOL, BERN, SWITZERLAND
关键词
D O I
10.1177/106002809703100113
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the current literature regarding the role of apoptosis in the development of malignant cells and how the induction of this pathway could be used in cancer therapy. DATA SOURCE: A MEDLINE search of basic science articles pertinent to the understanding of the normal physiologic process of apoptosis was conducted. STUDY SELECTION: Because of the rapidly growing literature regarding apoptosis, only articles describing key processes in the biology of the cell and the genetic control of apoptosis were included. DATA SYNTHESIS: Apoptosis is imperative for host survival since it discards unwanted, damaged, and atypical cells. The process is therefore implicated in the continuous regulation of development differentiation, and homeostasis. Furthermore, apoptosis is a response to physiologic and pathologic stresses that disrupt the balanced rates of cell generation and elimination, In a disease such as cancer, there is a lack of equilibrium between the rates of cell division and cell death; agents that promote or suppress apoptosis can manipulate these rates, influencing the anomalous accumulation of neoplastic cells. Pharmacologic manipulation of apoptosis represents a novel approach in targeting malignant cells and has far-reaching implications for new directions in cancer therapy. CONCLUSIONS: Apoptosis is a highly organized physiologic mechanism of destroying injured and abnormal cells as well as maintaining homeostasis in multicellular organisms. Both the activation and inhibition of apoptosis are tightly controlled, Pharmacologic manipulation of this pathway is a novel therapeutic target in cancer therapy.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 81 条
  • [1] APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA - NORMAL RESPONSES BY PROGENITOR CELLS TO GROWTH-FACTOR DEPRIVATION, X-IRRADIATION AND GLUCOCORTICOIDS
    AMOS, TAS
    LEWIS, JL
    GRAND, FH
    GOODING, RP
    GOLDMAN, JM
    GORDON, MY
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 387 - 393
  • [2] ANTALIKOVA L, 1989, FOLIA BIOL-PRAGUE, V35, P339
  • [3] ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
  • [4] IDENTIFICATION OF DEOXYRIBONUCLEASE-II AS AN ENDONUCLEASE INVOLVED IN APOPTOSIS
    BARRY, MA
    EASTMAN, A
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 300 (01) : 440 - 450
  • [5] CASEIN KINASE-1 PHOSPHORYLATES THE P75 TUMOR-NECROSIS-FACTOR RECEPTOR AND NEGATIVELY REGULATES TUMOR-NECROSIS-FACTOR SIGNALING FOR APOPTOSIS
    BEYAERT, R
    VANHAESEBROECK, B
    DECLERCQ, W
    VANLINT, J
    VANDENABEELE, P
    AGOSTINIS, P
    VANDENHEEDE, JR
    FIERS, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23293 - 23299
  • [6] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [7] DNA-DAMAGE RESPONSES - P53 INDUCTION, CELL-CYCLE PERTURBATIONS, AND APOPTOSIS
    CANMAN, CE
    CHEN, CY
    LEE, MH
    KASTAN, MB
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 277 - 286
  • [8] CANCER PROGRESSION AND P53
    CARSON, DA
    LOIS, A
    [J]. LANCET, 1995, 346 (8981): : 1009 - 1011
  • [9] APOPTOSIS AND DISEASE
    CARSON, DA
    RIBEIRO, JM
    [J]. LANCET, 1993, 341 (8855) : 1251 - 1254
  • [10] COHEN JJ, 1984, J IMMUNOL, V132, P38